AQR Arbitrage’s Amicus Therapeutics FOLD Stock Holding History

AQR Arbitrage’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,843,849	Closed	-$84.5M	–	652
2026 Q1	$84.5M	Buy	5,843,849 +3,860,740	+195%	+$55.3M	1.39%	14
2025 Q4	$28.2M	Buy	+1,983,109	New	+$19.5M	0.59%	40

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

AQR Arbitrage's FOLD Position: Q2 2026 in Review

AQR Arbitrage sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 5,843,849 shares — an estimated $84.5M sold.

AQR Arbitrage first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $84.5M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

AQR Arbitrage reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
AQR Arbitrage sold 5,843,849 Amicus Therapeutics shares in Q2 2026, an estimated $84.5M.
AQR Arbitrage first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
AQR Arbitrage's Amicus Therapeutics position peaked at $84.5M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.